Direct thrombin inhibitors: appraisal of the antithrombotic/hemorrhagic balance
Verstraete, M.
Thrombosis and Haemostasis 78(1): 357-363
1997
ISSN/ISBN: 0340-6245 PMID: 9198179 Document Number: 474219
Document emailed within 1 workday
Related Documents
Brill-Edwards, P.; Van Ryn-McKenna, J.; Cai, L.; Ofosu, F.A.; Buchanan, M.R. 1992: Prevention of thrombus growth by antithrombin III-dependent and two direct thrombin inhibitors in rabbits: implications for antithrombotic therapy Thrombosis and Haemostasis 68(4): 424-427Van De Werf, F. 1999: Specific thrombin inhibitors ... only one tool of the antithrombotic armamentarium European Heart Journal 20(7): 479-480
Momi, S.; Nasimi, M.; Colucci, M.; Nenci, G.G.; Gresele, P. 2001: Low molecular weight heparins prevent thrombin-induced thrombo-embolism in mice despite low anti-thrombin activity. Evidence that the inhibition of feed-back activation of thrombin generation confers safety advantages over direct thrombin inhibition Haematologica 86(3): 297-302
Gandossi, E.; Lunven, C.; Gauffeny, C.; Roome, N.O.; Berry, C.N. 1998: Platelet aggregation induced in vitro by rabbit plasma clot-associated thrombin, and its inhibition by thrombin inhibitors Thrombosis and Haemostasis 80(5): 840-844
Prasa, D.; Svendsen, L.; Stürzebecher, J. 1997: The ability of thrombin inhibitors to reduce the thrombin activity generated in plasma on extrinsic and intrinsic activation Thrombosis and Haemostasis 77(3): 498-503
Tapparelli, C.; Metternich, R.; Gfeller, P.; Gafner, B.; Powling, M. 1995: Antithrombotic activity in vivo of SDZ 217-766, a low-molecular weight thrombin inhibitor in comparison to heparin Thrombosis and Haemostasis 73(4): 641-647
Alvarez-Sabín, J. 2001: Hemorrhagic stroke antithrombotic drugs Revista de Neurologia 32(9): 848-850
DiMinno, G.; Silver, M.J. 1983: Mouse antithrombotic assay: a simple method for the evaluation of antithrombotic agents in vivo. Potentiation of antithrombotic activity by ethyl alcohol Journal of Pharmacology and Experimental Therapeutics 225(1): 57-60
Jackson, C.V.; Crowe, V.G.; Frank, J.D.; Wilson, H.C.; Coffman, W.J.; Utterback, B.G.; Jakubowski, J.A.; Smith, G.F. 1992: Pharmacological assessment of the antithrombotic activity of the peptide thrombin inhibitor, D-methyl-phenylalanyl-prolyl-arginal (GYKI-14766), in a canine model of coronary artery thrombosis Journal of Pharmacology and Experimental Therapeutics 261(2): 546-552
Stone, G.W. 2004: Advantages of direct thrombin inhibition in high- and low-risk patients Journal of Invasive Cardiology 16 Suppl G: 12-17
Hauptmann, J. 1982: Pharmacology of benzamidine-type thrombin inhibitors Folia Haematologica 109(1): 89-97
Poiarkov, A.A.; Timoshok, N.A.; Spivak, N.I.; Poiarkova, S.A. 2010: Thrombin inhibitors which display antibacterial activity Ukrains'kyi Biokhimichnyi Zhurnal 82(1): 123-129
Prasa, D.; Svendsen, L.; Stürzebecher, J. 1997: Inhibition of thrombin generation in plasma by inhibitors of factor Xa Thrombosis and Haemostasis 78(4): 1215-1220
Menear, K. 1998: Progress towards the discovery of orally active thrombin inhibitors Current Medicinal Chemistry 5(6): 457-468
Bode, A.P.; Miller, D.T. 1989: The use of thrombin inhibitors and aprotinin in the preservation of platelets stored for transfusion Journal of Laboratory and Clinical Medicine 113(6): 753-758
Vogel, C.N.; Kingdon, H.S.; Lundblad, R.L. 1979: Correlation of in vivo and in vitro inhibition of thrombin by plasma inhibitors Journal of Laboratory and Clinical Medicine 93(4): 661-673
Boneu, B.; Sie, P.; Caranobe, C.; Cassigneul, J.; Pascal, J. 1982: Progressive antithrombin activity and the concentration of three thrombin inhibitors in liver cirrhosis Thrombosis and Haemostasis 47(1): 78
Wojewódzka-Zelezniakowicz, M.; Chabielska, E.; Mogielnicki, A.; Kramkowski, K.; Karp, A.; Opadczuk, A.; Domaniewski, T.; Malinowska-Zaprzałka, M.; Buczko, W. 2006: Antithrombotic effect of tissue and plasma type angiotensin converting enzyme inhibitors in experimental thrombosis in rats Journal of Physiology and Pharmacology: An Official Journal of the Polish Physiological Society 57(2): 231-245
Chen, L.; Nichols, W.W.; Mattsson, C.; Teger-Nilsson, A.C.; Saldeen, T.G.; Mehta, J.L. 1996: Inogatran, a novel direct low molecular weight thrombin inhibitor, given with, but not after, tissue-plasminogen activator, improves thrombolysis Journal of Pharmacology and Experimental Therapeutics 277(3): 1276-1283
Okamoto, S.; Hijikata, A.; Kinjo, K.; Kikumoto, R.; Okubo, K. 1975: A novel series of synthetic thrombin-inhibitors having extremely potent and highly selective action Kobe Journal of Medical Sciences 21(2): 43-51